Fig. 3From: Effect of different direct-acting antiviral regimens for treatment of nondiabetic hepatitis C virus–infected Egyptian patients on insulin resistance and sensitivityA Comparison between lipid profiles at baseline and after SVR at 12 weeks among patients in group B. B Comparison between 2-h postprandial blood glucose and mean glucose levels at baseline and after SVR at 12 weeks among patients in group B. C Comparison between HbA1C, fasting insulin, and mean insulin levels at baseline and after SVR at 12 weeks among patients in group BBack to article page